Tura advises Dark Peak Analytics on joining Initiate
Sector
Health Economics & Data Science
Seller
Dark Peak Analytics United Kingdom
Buyer
Inititate United Kingdom
Date
August 2026
The deal at a glance
Dark Peak Analytics, a specialist health economics modelling and software development consultancy, has joined Initiate Consultancy (backed by Queen’s Park Equity) in a transaction advised by Tura Advisory.
Tura’s role in the transaction
Tura Advisory acted as the exclusive sell-side advisor to Dark Peak Analytics.
“Tura were instrumental in helping us navigate the transaction through to a successful outcome. Tim brought strong commercial judgement, deep sector knowledge and a clear understanding of the issues that mattered most. His hands-on approach and practical advice were invaluable throughout, and I would have no hesitation in recommending Tim and Tura.”
Dr Robert Smith, MD, Dark Peak Analytics
Combining end-to-end market access, HEOR and analytics business
Dark Peak Analytics is a specialist health economics modelling and software development consultancy, combining scientific expertise, advanced analytical methods and technology-enabled solutions to support evidence-based healthcare decision-making. The business builds bespoke decision models and analytical platforms and has developed a proprietary Structured Expert Elicitation (SEE) platform that enables clients to capture, aggregate and report expert evidence for use in health economic models.
Initiate Consultancy is a specialist global market access and HEOR consultancy, supporting pharmaceutical, biotechnology and healthcare clients across evidence generation, value demonstration, pricing, reimbursement and patient access. Backed by Queen’s Park Equity, Initiate has developed more than 130 HTA submissions across multiple global markets, with a 98% submission success rate, and works with over 80 global pharmaceutical clients and affiliates across rare and complex disease areas.
“Bringing Dark Peak and Initiate together creates a unique opportunity to integrate advanced analytics, health economic modelling, HEOR and market access expertise within a single platform. This provides a stronger foundation for innovation and enables us to deliver more efficient, scalable and impactful solutions for clients.”
Dr Robert Smith, MD, Dark Peak Analytics
“We are combining deep expertise across market access, HTA, HEOR, analytics and technology to create a truly integrated, end-to-end offering. Our ambition is not simply to add capabilities together, but to build a more connected, technology-enabled model that helps clients make better decisions and achieve faster, broader patient access.”
Andrew Mumford, CEO, Initiate
What this deal says about the market
This deal reflects the growing demand for integrated capabilities across the life sciences services sector. As EU Joint Clinical Assessment (JCA), evolving Health Technology Assessment (HTA) frameworks and Most Favoured Nation (MFN) pricing create greater complexity for pharmaceutical and biotech clients, the value of businesses that can combine rigorous scientific modelling with strategic market access expertise continues to grow. Businesses with proprietary technology, reproducible methodologies and deep client relationships in complex disease areas represent an increasingly attractive proposition for acquirers and investors building out end-to-end platforms in this space.
Further information on the deal can be found here.
If you are a healthcare or life sciences business considering your strategic options and would like to speak to Tura about what is possible, please get in touch.
For more information on this deal, reach
out to Head of Healthcare & Life Sciences, Tim Sturgeon
↖ Back to Experience